nnc 112 has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aisaborhale, E; Borra, RH; Granda, ML; Guimaraes, AR; Hooker, JM; Schauer, N; Schroeder, FA | 1 |
Abi-Dargham, A; Guo, N; Huang, YY; Hwang, DR; Laruelle, M; Lo, ES | 1 |
2 other study(ies) available for nnc 112 and Disease Models, Animal
Article | Year |
---|---|
First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.
Topics: Animals; Benzazepines; Benzofurans; Disease Models, Animal; Dopamine; Dopamine Antagonists; Kidney; Papio anubis; Positron-Emission Tomography; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Renin-Angiotensin System | 2014 |
Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Topics: Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Benzazepines; Benzofurans; Binding Sites; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; Hippocampus; Male; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reserpine; Schizophrenia; Time Factors; Tritium | 2003 |